Real-World Evidence Supporting Tandem Control-IQ Hybrid Closed-Loop Success in the Medicare and Medicaid Type 1 and Type 2 Diabetes Populations

BACKGROUND: The Tandem Control-IQ (CIQ) system has demonstrated significant glycemic improvements in large randomized controlled and real-world trials. Use of this system is lower in people with type 1 diabetes (T1D) government-sponsored insurance and those with type 2 diabetes (T2D). This analysis...

Descripción completa

Detalles Bibliográficos
Autores principales: Forlenza, Gregory P., Carlson, Anders L., Galindo, Rodolfo J., Kruger, Davida F., Levy, Carol J., McGill, Janet B., Umpierrez, Guillermo, Aleppo, Grazia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mary Ann Liebert, Inc., publishers 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9618372/
https://www.ncbi.nlm.nih.gov/pubmed/35763323
http://dx.doi.org/10.1089/dia.2022.0206

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9618372/
https://www.ncbi.nlm.nih.gov/pubmed/35763323
http://dx.doi.org/10.1089/dia.2022.0206

Ejemplares similares